LDLc | HDLc | CAD | ASCVD |TGRL
Serum non-HDL-C, easily assessed through routine lipid panels, has been suggested as an effective surrogate marker for small-dense LDL-C.
📍However, it is important to remember that we are faced with present and established ASCVD lesions, which we have to try to minimize their inexorable evolution!
❗️The analytical bilan in the context of primary prevention as well as medical interventions prior to ASCVD injuries are located at a level of diagnostic assessment and therapeutic intervention that the present study does not allow to evaluate,
‼️namely the importance of TG, ApoA, ApoB, LDLc and TGRL, RC and the importance in relation to the use of Fenofibrate, Statins-Ezetimibe and other therapies available for prevention and treatment of CVD.